Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

NCT00485719 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi